Hillenbrand Inc. has announced the sale of a 51% stake in its Milacron injection molding and extrusion business to an ...
Hillenbrand's stock faces challenges due to subdued demand, impairment charges, and high debt. Read why I remain neutral on ...
5d
Hillenbrand anticipates Q2 revenue in the range of $685 million to $705 million and adjusted EPS between $0.53 and $0.58. Full-year guidance has been updated to reflect the Milacron transaction, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback